Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|September 15, 2016
Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinicAngelo B A Laranjeira, Sherry X Yang
Diseases (Basel, Switzerland)|July 26, 2024
Upregulation of TET2 and Resistance to DNA Methyltransferase (DNMT) Inhibitors in DNMT1-Deleted Cancer CellsAngelo B A Laranjeira, Dat Nguyen, Lorraine C Pelosof, et al.
Experimental Hematology & Oncology|June 23, 2017
Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritisSilvia R Brandalise, Rosemary Assis, Angelo B A Laranjeira, et al.
Springerplus|March 31, 2016
Simultaneous detection of lysine metabolites by a single LC-MS/MS method: monitoring lysine degradation in mouse plasmaIzabella A Pena, Lygia A Marques, Angelo B A Laranjeira, et al.
Scientific Reports|April 12, 2023
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitorsAngelo B A Laranjeira, Melinda G Hollingshead, Dat Nguyen, et al.
American Journal of Hematology|May 19, 2023
Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasmsTim Kong, LaYow Yu, Angelo B A Laranjeira, et al.
Experimental Hematology|August 23, 2023
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in miceDaniel A C Fisher, Angelo B A Laranjeira, Tim Kong, et al.
Cancer Research|May 20, 2011
IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemiasAna Silva, Angelo B A Laranjeira, Leila R Martins, et al.
Blood|March 8, 2024
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasmsAngelo B A Laranjeira, Tim Kong, Steven C Snyder, et al.
Blood Cancer Journal|November 26, 2024
RSK1 dependency in FLT3-ITD acute myeloid leukemiaTim Kong, Angelo B A Laranjeira, Christopher T Letson, et al.
Pageof 2